New Additions to Drugs.com for 2021
The following 69 drugs were added to the Drugs.com database in 2021.
Adbry
Dec 30, 2021 - Adbry (tralokinumab-ldrm) is an interleukin-13 (IL-13) inhibitor that may be used to treat adults and children aged 12 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with other topical prescription treatments or those treatments are not advised.
Apretude
Dec 23, 2021 - Apretude (cabotegravir) is a long-acting injectable integrase strand transfer inhibitor (INSTI) indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
Tezspire
Dec 23, 2021 - Tezspire (Tezepelumab-ekko) is an add-on, injectable treatment that can be self-administered under the skin every 4 weeks for the maintenance treatment of severe asthma in people 12 years of age and older, whose asthma is not controlled with their current asthma medicine. It can help prevent severe asthma attacks and improve breathing but is not a rescue medication and will not relieve acute bronchospasm or status asthmaticus.
Paxlovid
Dec 22, 2021 -
Tarpeyo
Dec 20, 2021 - Tarpeyo (budesonide) is an oral, delayed-release, corticosteroid capsule that may be used to reduce inflammation and the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.
Entadfi
Dec 14, 2021 - Entadfi (finasteride and tadalafil) is a 5α-reductase inhibitor and phosphodiesterase 5 (PDE5) inhibitor combination indicated for the treatment of urinary tract symptoms caused by benign prostatic hyperplasia (BPH).
Lyvispah
Nov 25, 2021 - Lyvispah (baclofen) is an oral granule formulation of the approved gamma-aminobutyric acid agonist baclofen used for the treatment of spasticity
Livtencity
Nov 25, 2021 - Livtencity (maribavir) is a cytomegalovirus (CMV) pUL97 kinase inhibitor used for the treatment of post-transplant CMV infection/disease.
Voxzogo
Nov 23, 2021 - Voxzogo (vosoritide) is a C-type natriuretic peptide (CNP) analog that is given by subcutaneous injection and may be used to increase linear bone growth in children with achondroplasia with open bone growth plates (epiphyses).
Besremi
Nov 17, 2021 - Besremi (ropeginterferon-alfa-2b-njft) is an interferon alfa-2b indicated for the treatment of adults with polycythemia vera.
Eprontia
Nov 8, 2021 - Eprontia (topiramate) is a ready-to-use liquid formulation of the approved anticonvulsant topiramate for use in the treatment of epilepsy, and the preventive treatment of migraine.
Scemblix
Oct 30, 2021 -
Susvimo
Oct 27, 2021 - Susvimo (ranibizumab) is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with Neovascular (wet) Age-related Macular Degeneration (AMD) who have previously responded to at least two intravitreal injections of a VEGF inhibitor.
Alprolix
Oct 20, 2021 - Alprolix (coagulation factor IX (recombinant)) is a clotting factor IX therapy indicated to prevent bleeding in patients with hemophilia B.
Tyrvaya
Oct 20, 2021 - Tyrvaya (varenicline solution) is a nasally administered selective cholinergic agonist for the treatment of the signs and symptoms of dry eye disease.
Seglentis
Oct 19, 2021 - Seglentis (celecoxib and tramadol hydrochloride) is a nonsteroidal anti-inflammatory drug (NSAID) and opioid agonist combination indicated for the management of acute pain in adults.
Zimhi
Oct 18, 2021 - Zimhi (naloxone hydrochloride) is a high-dose formulation of the approved opioid antagonist naloxone for use in the treatment of opioid overdose.
Tavneos
Oct 11, 2021 - Tavneos (avacopan) is a complement 5a receptor (C5aR) antagonist for the adjunctive treatment of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
Livmarli
Sep 30, 2021 - Livmarli is an ileal bile acid transporter (IBAT) inhibitor that may be used to treat cholestatic pruritus (skin itching caused by a build-up of bile salts in the blood) associated withAlagille syndrome (ALGS) in adults and children aged 3 months and older, and progressive familial intrahepatic cholestasis (PFIC) in adults and children aged at least 5 years.
Qulipta
Sep 29, 2021 - Qulipta (atogepant) is an oral, calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the preventive treatment of migraine in adults.
Opzelura
Sep 28, 2021 -
Tivdak
Sep 21, 2021 - Tivdak (tisotumab vedotin-tftv) is a tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of cervical cancer.
Exkivity
Sep 16, 2021 - Exkivity (mobocertinib) is an oral tyrosine kinase inhibitor for the treatment of adult patients with epidermal growth factor receptor (EGFR) exon20 insertion mutation-positive (insertion+) metastatic non-small cell lung cancer (mNSCLC).
Moderna COVID-19 Vaccine
Sep 11, 2021 - The Moderna COVID-19 (2023-2024 Formula) (COVID-19 Vaccine, mRNA) is a vaccine that may help your body develop immunity to SARS-CoV-2, the virus that causes COVID-19. The Moderna COVID-19 vaccine is an FDA-approved vaccine for adults and adolescents aged 12 years and also has emergency use authorization (EUA) for children aged 6 months to 11 years.
Janssen - Johnson & Johnson COVID-19 Vaccine
Sep 11, 2021 - Janssen - Johnson & Johnson COVID-19 Vaccine may help prevent infection with COVID-19.
Pfizer-BioNTech COVID-19 Vaccine
Sep 11, 2021 - The Pfizer-BioNTech COVID-19 Vaccine 2023-2024 Formula (COVID-19 Vaccine, mRNA) is a vaccine made by Pfizer and BioNTech that may help your body develop immunity to SARS-CoV-2, the virus that causes COVID-19.
Regen-Cov
Sep 10, 2021 - Regen-Cov is an investigational medicine used to treat mild to moderate symptoms of COVID-19 and to prevent infection after exposure to coronavirus.
Trudhesa
Sep 4, 2021 - Trudhesa (dihydroergotamine) is an ergotamine derivative nasal spray is an indicated for the acute treatment of migraine with or without aura in adults.
Invega Hafyera
Sep 2, 2021 - Invega Hafyera (paliperidone palmitate) is a long-acting injectable atypical antipsychotic for the twice-yearly treatment of schizophrenia in adults.
Comirnaty
Aug 24, 2021 - Comirnaty 2023-2024 Formula (COVID-19 Vaccine, mRNA) is a vaccine made by Pfizer and BioNTech that may help your body develop immunity to SARS-CoV-2, the virus that causes COVID-19.
Welireg
Aug 16, 2021 - Welireg (belzutifan) is a selective inhibitor of hypoxia-inducible factor 2 alpha (HIF-2α) for the treatment of adult patients with von Hippel-Lindau (VHL) disease-associated tumors, and certain advanced renal cell carcinomas (RCC).
Saphnelo
Aug 3, 2021 - Saphnelo (anifrolumab) is a type I interferon (IFN) receptor antagonist indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy.
Twyneo
Jul 27, 2021 - Twyneo (tretinoin and benzoyl peroxide) is a topical retinoid and antibacterial fixed-dose combination for the treatment of acne vulgaris in adults and children 9 years of age and older.
Vaxneuvance
Jul 19, 2021 - Vaxneuvance (pneumococcal 15-valent conjugate vaccine) is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F.
Rezurock
Jul 17, 2021 - Rezurock (belumosudil) is a kinase inhibitor for the treatment of patients with chronic graft-versus-host disease (cGVHD).
Kerendia
Jul 12, 2021 - Kerendia (finerenone) is a non-steroidal, selective mineralocorticoid receptor antagonist (MRA) indicated for the treatment of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
Ryplazim
Jun 16, 2021 - Ryplazim (plasminogen, human-tvmh) is a plasma-derived plasminogen replacement therapy for the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenia).
Tembexa
Jun 8, 2021 - Tembexa (brincidofovir) is a nucleotide analog broad-spectrum antiviral indicated for use as a medical countermeasure for smallpox.
Aduhelm
Jun 7, 2021 - Aduhelm (aducanumab-avwa) is an amyloid beta-directed antibody indicated for the treatment of Alzheimer’s disease.
Wegovy
Jun 5, 2021 - Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise for chronic weight management in adult patients who are overweight (BMI ≥27 kg/m2) or obese (BMI ≥30 kg/m2).
Brexafemme
Jun 2, 2021 -
Lybalvi
Jun 2, 2021 - Lybalvi (olanzapine and samidorphan) is a combination of an antipsychotic agent (olanzapine) and an opioid receptor antagonist (samidorphan) for the treatment of schizophrenia and bipolar I disorder.
Lumakras
May 31, 2021 - Lumakras (sotorasib) is a KRASG12C inhibitor for the treatment of patients with KRAS G12C-mutated locally advanced or metastatic non- small cell lung cancer (NSCLC), following at least one prior systemic therapy.
Truseltiq
May 31, 2021 - Truseltiq (infigratinib) is an FGFR tyrosine kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.
Myfembree
May 26, 2021 -
Rybrevant
May 24, 2021 - Rybrevant (amivantamab-vmjw) is a bispecific EGF receptor-directed and MET receptor-directed antibody indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
Empaveli
May 17, 2021 - Empaveli (pegcetacoplan) is a targeted C3 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Kloxxado
May 2, 2021 - Kloxxado (naloxone hydrochloride) nasal spray is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.
Zynlonta
Apr 27, 2021 - Zynlonta (loncastuximab tesirine-lpyl) is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.
Jemperli
Apr 27, 2021 -
Nextstellis
Apr 21, 2021 - Nextstellis (drospirenone and estetrol) is a progestin and estrogen combination indicated for use by females of reproductive potential to prevent pregnancy.
Mydayis
Apr 9, 2021 - Mydayis (amphetamine mixed salts) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.
Qelbree
Apr 6, 2021 - Qelbree (viloxazine hydrochloride) is a serotonin norepinephrine modulating agent (SNMA) for the treatment of attention deficit hyperactivity disorder (ADHD).
Roszet
Apr 1, 2021 - Roszet (ezetimibe and rosuvastatin) is a combination of the approved intestinal cholesterol inhibitor ezetimibe (Zetia) and the HMG Co-A reductase inhibitor rosuvastatin (Crestor) indicated for use in adults to reduce low-density lipoprotein cholesterol (LDL-C) in patients with primary non-familial hyperlipidemia and patients with homozygous familial hypercholesterolemia (HoFH).
Abecma
Mar 28, 2021 - Abecma (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous chimeric antigen receptor (CAR) T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma.
Zegalogue
Mar 25, 2021 - Zegalogue (dasiglucagon) is a glucagon analog antihypoglycemic agent for the treatment of severe hypoglycemia in diabetes patients aged 6 years and older.
Ponvory
Mar 21, 2021 - Ponvory (ponesimod) is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator for the treatment of adult patients with relapsing multiple sclerosis (MS).
Fotivda
Mar 14, 2021 - Fotivda (tivozanib) is a tyrosine kinase inhibitor for the treatment of advanced renal cell carcinoma.
Pepaxto
Mar 10, 2021 - Pepaxto (melphalan flufenamide) is an anticancer peptide-drug conjugate indicated for use in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.
Azstarys
Mar 3, 2021 - Azstarys (dexmethylphenidate and serdexmethylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.
Evkeeza
Feb 13, 2021 - Evkeeza (evinacumab-dgnb) is an angiopoietin-like 3 (ANGPTL3) inhibitor indicated for the treatment of patients with homozygous familial hypercholesterolemia (HoFH).
Breyanzi
Feb 9, 2021 - Breyanzi (lisocabtagene maraleucel) is a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of large B-cell lymphoma, relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL),
Ukoniq
Feb 8, 2021 - Ukoniq (umbralisib) is an oral, once-daily, dual inhibitor of PI3K-delta and CK1-epsilon for the treatment for patients with previously treated marginal zone lymphoma (MZL) and follicular Lymphoma (FL).
Tepmetko
Feb 3, 2021 - Tepmetko is an oral (taken by mouth) kinase inhibitor that may be used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic), and whose tumors have an abnormal mesenchymal-epithelial transition (MET) gene. Your healthcare provider will perform a test to make sure that Tepmetko is right for you.
Vocabria
Jan 27, 2021 - Vocabria (cabotegravir) is a prescription medicine used in combination with Edurant (rilpivirine) as part of the Cabenuva (cabotegravir, rilpivirine) injectable treatment regimen for adults with HIV-1 infection.
Lupkynis
Jan 26, 2021 - Lupkynis (voclosporin) is a calcineurin-inhibitor immunosuppressant indicated for the treatment of adults with active lupus nephritis (LN).
Cabenuva
Jan 23, 2021 - Cabenuva (cabotegravir and rilpivirine) is a long-acting, injectable regimen of the HIV-1 integrase strand transfer inhibitor (INSTI) cabotegravir, and the HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine indicated as a complete regimen for the treatment of HIV-1 infection in adults.
Verquvo
Jan 21, 2021 - VERQUVO is a prescription medicine used to treat adults who have chronic heart failure with reduced ejection fraction (HFrEF).
Gemtesa
Jan 1, 2021 - Gemtesa (vibegron) is a prescription medicine used to treat urge urinary incontinence, urinary urgency, and urinary frequency due to overactive bladder.